APA
WST icon

American Portfolios Advisors’s West Pharmaceutical WST Stock Holding History

American Portfolios Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$302K Sell
1,229
-27
-2% -$8.22K 0.01% 851
2022
Q2 		$380K Sell
1,256
-118
-9% -$38.4K 0.02% 775
2022
Q1 		$564K Sell
1,374
-877
-39% -$343K 0.02% 683
2021
Q4 		$1.06M Buy
2,251
+886
+65% +$381K 0.04% 465
2021
Q3 		$579K Buy
1,365
+145
+12% +$61.1K 0.02% 638
2021
Q2 		$438K Buy
1,220
+19
+2% +$6.28K 0.02% 770
2021
Q1 		$338K Sell
1,201
-22
-2% -$6.3K 0.01% 820
2020
Q4 		$346K Sell
1,223
-2,552
-68% -$716K 0.02% 678
2020
Q3 		$1.04M Buy
3,775
+3,545
+1,541% +$938K 0.06% 291
2020
Q2 		$52.2K Sell
230
-11
-5% -$2.16K ﹤0.01% 1277
2020
Q1 		$36.7K Sell
241
-47
-16% -$7.23K ﹤0.01% 1294
2019
Q4 		$43.3K Sell
288
-564
-66% -$82.1K ﹤0.01% 1401
2019
Q3 		$121K Buy
852
+480
+129% +$66.1K 0.01% 910
2019
Q2 		$46.6K Sell
372
-80
-18% -$9.44K ﹤0.01% 1310
2019
Q1 		$49.8K Buy
452
+224
+98% +$23.3K ﹤0.01% 1200
2018
Q4 		$22.4K Sell
228
-26
-10% -$2.82K ﹤0.01% 1331
2018
Q3 		$31.4K Sell
254
-22
-8% -$2.47K ﹤0.01% 1305
2018
Q2 		$27.4K Buy
276
+250
+962% +$23K ﹤0.01% 1332
2018
Q1 		$2.3K Buy
26
+8
+44% +$748 ﹤0.01% 2078
2017
Q4 		$1.78K Buy
+18
New +$1.76K ﹤0.01% 2075

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Portfolios Advisors's WST Position: Q3 2022 in Review

American Portfolios Advisors reduced its West Pharmaceutical (WST) stake by 2.1% in Q3 2022, selling an estimated $8.22K and leaving 1,229 shares worth $302K. The position accounts for 0.01% of the portfolio, ranked #851.

American Portfolios Advisors first reported a position in WST in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.06M in Q4 2021. 639 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • American Portfolios Advisors held 1,229 shares of West Pharmaceutical worth $302K as of Q3 2022.
  • American Portfolios Advisors sold 27 West Pharmaceutical shares in Q3 2022, an estimated $8.22K.
  • West Pharmaceutical made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #851 holding.
  • American Portfolios Advisors first reported a position in West Pharmaceutical in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's West Pharmaceutical position peaked at $1.06M in Q4 2021.
  • 639 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.